Lilly continues to sweep court rulings regarding Alimta patent 12-Aug-2019 By Maggie Lynch Courts continue to rule in favor of Lilly’s lung cancer treatment patent, as the District Court for Appeals concludes generic producers like Dr Reddy’s to be potentially infringing.
Pfizer McPherson site hit with US FDA repeat observations 11-Dec-2018 By Ben Hargreaves Pfizer’s sterile drug manufacturing site in Kansas received eight observations during an FDA inspection.
Pfizer lowers guidance due to Hospira manufacturing issues 01-Nov-2018 By Ben Hargreaves Pfizer has updated its 2018 financial guidance due to ‘lower-than-anticipated’ Essential Health revenue.
UPDATED Pfizer halts production at Hospira site after Form 483 16-Jul-2018 By Flora Southey Pfizer says it has voluntarily paused production at a manufacturing facility in India, after receiving a US FDA Form 483 with 11 observations.